Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
State lab and regulators warn of unregistered high‑THC hemp products and synthetic compounds in consumer goods
Summary
Department officials told lawmakers the specialized products division and state lab found high rates of unregistered industrial hemp products, detected semi‑synthetic cannabinoids and novel psychoactive compounds in marketed items, and flagged resource constraints in enforcement and lab testing.
Cody James, deputy director of the Specialized Products Division, and Dr. Brandon Forsyth, director of Laboratory Services, told the appropriations subcommittee that the medical cannabis program has matured but that industrial hemp and kratom products pose enforcement and public‑health challenges.
James said the medical cannabis program currently operates under statutory caps (eight cultivator licenses and roughly 16 processors) with 47 overall licenses and about 15 pharmacies; in 2025 the eight cultivators…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
